Manufacturer: Cipla, India
Pharmaceutical name: Pack: 1 bottle (0.05%w/v 30 gm)
Clofoam is a potent topical corticosteroid preparation indicated for short-term topical treatment of the inflammatory and pruritic manifestations of:
* Moderate to severe corticosteroid-responsive dermatoses of the scalp.
* Mild to moderate plaque-type psoriasis of non-scalp regions, excluding the face and intertriginous areas.
Treatment beyond two consecutive weeks is not recommended, and the total dosage should not exceed 50 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
Dosage and administration
Clofoam should be applied to the affected scalp area twice daily, once in the morning and once at night. Invert the can and dispense a small amount of foam into the cap of the can. Dispensing directly onto hands is not recommended, as the foam will begin to melt immediately upon contact with warm skin. Move the hair away from the affected area of the scalp so that the foam can be applied to each affected area. Gently massage foam into affected scalp area until the foam disappears. Repeat until entire affected scalp area is treated.
Apply the smallest amount possible that sufficiently covers the affected area(s). No more than 1½ capfuls of foam should be used at each application. Do not apply to the face, or intertriginous areas. Unless directed by a physician, Clofoam should not be used with occlusive dressings.
Contraindications
Clofoam is contraindicated in patients who are hypersensitive to clobetasol propionate, to other corticosteroids, or to any ingredient in this preparation. Clofoam is a super-high-potency topical corticosteroid; therefore, treatment should be limited to 2 consecutive weeks and amounts greater than 50 g/week should not be used. Use in pediatric patients under 12 years of age is not recommended.
